康华生物2025年第三季度净利润同比下降24.92%

Core Viewpoint - Kanghua Biological announced its financial results for Q3 2025, showing a revenue increase but a significant decline in net profit compared to the previous year [1] Financial Performance - In Q3 2025, the company achieved a revenue of 356 million yuan, representing a year-on-year growth of 11.54% [1] - The net profit attributable to shareholders was 74.59 million yuan, a decrease of 24.92% year-on-year [1] - The net profit excluding non-recurring gains and losses was 71.76 million yuan, down 30.82% year-on-year [1] Year-to-Date Performance - For the first three quarters of 2025, the company reported a total revenue of 840 million yuan, which is a decline of 20.78% compared to the same period last year [1] - The net profit attributable to shareholders for the first three quarters was 189 million yuan, reflecting a significant decrease of 53.41% year-on-year [1] - The net profit excluding non-recurring gains and losses for the same period was 183 million yuan, down 55.57% year-on-year [1]